Industry Commentary
BioAlberta works with policymakers at all levels for a coordinated approach to setting public policy initiatives and ensuring the life sciences industry’s critical issues are well represented.

/ Advocacy / Industry Commentary
Through our Advocacy and Policy Committee, BioAlberta focuses on legislative and regulatory policy at the provincial level.
However, we also work with partner life science organizations across the country to support federal regulatory issues. Our Advocacy and Policy Committee is divided into subcommittees to answer the unique needs of each of the life science sectors.
Priority activities include:
- Coverage of critical legislation and regulatory policy
- Educating public officials about biotechnology
- Encouraging greater support for life sciences entrepreneurship
- Simplifying the regulatory environment, among other issues

Commentary
Canadas life sciences associations are aligned against the proposed changes to capital gains in Canada.
Canadas life sciences associations are aligned against the proposed changes to capital gains in Canada.
View more
Policy Development
View all
Canadas life sciences associations are aligned against the proposed changes to capital gains in Canada.
Canadas life sciences associations are aligned against the proposed changes to capital gains in Canada.
Canadas life sciences associations are aligned against the proposed changes to capital gains in Canada.
View more